Status:
UNKNOWN
Micro Array Analysis in Preeclampsia
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Preeclampsia
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Preeclampsia is a frequent pathology. His etiology is doubtful. Targets : The study target is to identify a risk of preeclampsia group obtained with transcriptom analysis from circulating peripheric...
Eligibility Criteria
Inclusion
- A prééclampsie (blood pressure superior to 140 mmHg and to 90 mmHg) and at least a cross of protein in the strip and/or more of 300mg / 24h after 20 LIMITED COMPANIES and before 34 limited companies.
- An informed consent signed by the patient will necessarily have to be obtained.
- Woman having been taken care during the pregnancy or at the time of the childbirth(delivery) by one of the participating teams to the current project.
- Caucasian Patient
- Wait primigeste and nullipare
Exclusion
- Major Patient protected by the law.
- Patient deprived of freedom for administrative or judicial reasons.
- Patient not benefiting from a national insurance scheme.
- Refusal of the patient to participate in the study.
- Not Caucasian Patient
- Multipare Wait
- Multiple Pregnancy
- Existence of foetal deformation explaining a delay of growth or a foetal death in utero.
- Age 18 years and \> 40 years.
- Absence of written consent or impossibility to receive the written consent (language or understanding).
Key Trial Info
Start Date :
June 15 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 25 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01914809
Start Date
June 15 2011
End Date
January 25 2021
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, France, 13354